vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and Millrose Properties, Inc. (MRP). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $189.5M, roughly 1.1× Millrose Properties, Inc.). Millrose Properties, Inc. runs the higher net margin — 64.5% vs 57.4%, a 7.1% gap on every dollar of revenue.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Millrose Properties, Inc. is a U.S.-based real estate enterprise primarily focused on the acquisition, ownership, operation, and management of income-generating multi-family residential assets. Its core markets span the U.S. Mid-Atlantic and Southeast regions, and it also offers professional property management services to select third-party property owners.
IDYA vs MRP — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $189.5M |
| Net Profit | $119.2M | $122.2M |
| Gross Margin | — | — |
| Operating Margin | 52.2% | 84.8% |
| Net Margin | 57.4% | 64.5% |
| Revenue YoY | — | — |
| Net Profit YoY | 330.1% | 285.8% |
| EPS (diluted) | $1.33 | $0.74 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $189.5M | ||
| Q3 25 | $207.8M | $179.3M | ||
| Q2 25 | — | $149.0M | ||
| Q1 25 | — | $82.7M | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | $0 | — | ||
| Q3 22 | $29.7M | — |
| Q4 25 | — | $122.2M | ||
| Q3 25 | $119.2M | $105.1M | ||
| Q2 25 | — | $112.8M | ||
| Q1 25 | — | $39.8M | ||
| Q3 24 | $-51.8M | — | ||
| Q2 24 | $-52.8M | — | ||
| Q1 24 | $-39.6M | — | ||
| Q3 22 | $1.6M | — |
| Q4 25 | — | 84.8% | ||
| Q3 25 | 52.2% | 85.3% | ||
| Q2 25 | — | 85.1% | ||
| Q1 25 | — | 55.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | 2.2% | — |
| Q4 25 | — | 64.5% | ||
| Q3 25 | 57.4% | 58.6% | ||
| Q2 25 | — | 75.7% | ||
| Q1 25 | — | 48.1% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | 5.4% | — |
| Q4 25 | — | $0.74 | ||
| Q3 25 | $1.33 | $0.63 | ||
| Q2 25 | — | $0.68 | ||
| Q1 25 | — | $0.39 | ||
| Q3 24 | $-0.60 | — | ||
| Q2 24 | $-0.68 | — | ||
| Q1 24 | $-0.53 | — | ||
| Q3 22 | $0.04 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $35.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $5.9B |
| Total Assets | $1.2B | $9.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $35.0M | ||
| Q3 25 | $786.9M | $242.6M | ||
| Q2 25 | — | $66.6M | ||
| Q1 25 | — | $89.5M | ||
| Q3 24 | $920.0M | — | ||
| Q2 24 | $701.7M | — | ||
| Q1 24 | $698.8M | — | ||
| Q3 22 | $386.2M | — |
| Q4 25 | — | $5.9B | ||
| Q3 25 | $1.1B | $5.9B | ||
| Q2 25 | — | $5.9B | ||
| Q1 25 | — | $5.9B | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $931.7M | — | ||
| Q1 24 | $935.3M | — | ||
| Q3 22 | $368.8M | — |
| Q4 25 | — | $9.3B | ||
| Q3 25 | $1.2B | $9.0B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.2B | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $973.7M | — | ||
| Q1 24 | $961.5M | — | ||
| Q3 22 | $410.9M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $3.7B |
| Free Cash FlowOCF − Capex | $142.2M | — |
| FCF MarginFCF / Revenue | 68.4% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | 1.19× | 30.05× |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.7B | ||
| Q3 25 | $142.2M | $123.1M | ||
| Q2 25 | — | $109.1M | ||
| Q1 25 | — | $21.3M | ||
| Q3 24 | $-49.2M | — | ||
| Q2 24 | $-32.9M | — | ||
| Q1 24 | $-43.8M | — | ||
| Q3 22 | $-24.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | $142.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $-49.7M | — | ||
| Q2 24 | $-33.9M | — | ||
| Q1 24 | $-45.1M | — | ||
| Q3 22 | $-25.3M | — |
| Q4 25 | — | — | ||
| Q3 25 | 68.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | -85.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | 3.7% | — |
| Q4 25 | — | 30.05× | ||
| Q3 25 | 1.19× | 1.17× | ||
| Q2 25 | — | 0.97× | ||
| Q1 25 | — | 0.53× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q3 22 | -14.96× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
